Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

UNCY Unicycive Therapeutics

Watchlist
0.528
+0.018+3.53%
Close  02/03 16:00 ET
0.520
-0.008-1.46%
Post Mkt Price 02/03 18:53 ET
High
0.559
Open
0.515
Turnover
342.46K
Low
0.444
Pre Close
0.510
Volume
627.38K
Market Cap
7.96M
P/E(TTM)
Loss
52wk High
1.640
Shares
15.09M
P/E(Static)
Loss
52wk Low
0.400
Float Cap
2.58M
Bid/Ask %
30.44%
Historical High
8.730
Shs Float
4.89M
Volume Ratio
1.25
Historical Low
0.400
Dividend TTM
--
Div Yield TTM
--
P/B
1.72
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
12.84%
Amplitude
22.47%
Avg Price
0.545
Lot Size
1
Float Cap
2.58M
Bid/Ask %
30.44%
Historical High
8.730
Shs Float
4.89M
Volume Ratio
1.25
Historical Low
0.400
Dividend TTM
--
P/B
1.72
Dividend LFY
--
Turnover Ratio
12.84%
Amplitude
22.47%
Avg Price
0.545
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Unicycive Therapeutics, Inc. engages in the development of treatment for kidney diseases. Its products include UNI-494, Renazorb, and UNI-220. The company was founded by Shalabh Gupta on August 18, 2016 and is headquartered in Los Altos, CA.
CEO: Dr. Shalabh Gupta, M.D.
Market: NASDAQ
Listing Date: 07/13/2021
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist